Related Experiment Video
Updated: Jul 14, 2026

Intraportal Transplantation of Pancreatic Islets in Mouse Model
Published on: May 5, 2018
[Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment]
1Medicinsk Afdeling, Endokrinologisk Funktion, Roskilde Sygehus, DK-4000 Roskilde. rserch@ra.dk
Posttransplant diabetes (PTDM) is persistent hyperglycemia following organ transplantation and is a serious and frequent complication. PTDM increases the risk of graft failure and cardiovascular disease. The most important factor is the posttransplant immunosuppressive treatment. PTDM develops when insulin resistance is not compensated by secretory hyperinsulinemia. New immunosuppressive regimes seem promising in reducing PTDM. Guidelines recommend pre-transplantation OGTT, early diagnose of PTDM and individualized immunosuppressive treatment. Antidiabetic treatment should be initiated early.
Posttransplant diabetes (PTDM) is persistent hyperglycemia following organ transplantation and is a serious and frequent complication. PTDM increases the risk of graft failure and cardiovascular disease. The most important factor is the posttransplant immunosuppressive treatment. PTDM develops when insulin resistance is not compensated by secretory hyperinsulinemia. New immunosuppressive regimes seem promising in reducing PTDM. Guidelines recommend pre-transplantation OGTT, early diagnose of PTDM and individualized immunosuppressive treatment. Antidiabetic treatment should be initiated early.
More Related Videos
Related Concept Videos
Kidney Transplant III: Nursing Management
Complications of Diabetes Mellitus
Type II Diabetes II: Pathophysiology
Kidney Transplant I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Kidney Transplant II: Surgical Procedure
